Other

Weighted-Average Discount Rate - Finance Leases

West Pharmaceutical Services Weighted-Average Discount Rate - Finance Leases decreased by 1.2% to $0.04 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 7.9%, from $0.04 to $0.04.

Analysis

StatementBalance Sheet Statement
SectionOther
CategoryLeverage
SignalContext dependent
VolatilityStable
First reportedQ4 2025
Last reportedQ1 2026

How to read this metric

Higher rates indicate increased financing costs for leased assets, while lower rates suggest more favorable financing terms or a lower interest rate environment.

Detailed definition

This metric represents the weighted average interest rate applied to discount future finance lease payments to their pre...

Peer comparison

Standardized metric across banking peers, reflecting the cost of financing equipment or property through lease structures.

Metric ID: weighted_average_discount_rate_finance_leases

Historical Data

8 periods
 Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0.05$0.05$0.05$0.04$0.04$0.04$0.04$0.04
QoQ Change-0.4%-2.4%-7.3%-3.8%-2.8%-0.2%-1.2%
YoY Change-13.4%-15.4%-13.5%-7.9%
Range$0.04$0.05
CAGR-10.1%
Avg YoY Growth-12.6%
Median YoY Growth-13.5%
Current Streak7+ quarters decline

Frequently Asked Questions

What is West Pharmaceutical Services's weighted-average discount rate - finance leases?
West Pharmaceutical Services (WST) reported weighted-average discount rate - finance leases of $0.04 in Q1 2026.
How has West Pharmaceutical Services's weighted-average discount rate - finance leases changed year-over-year?
West Pharmaceutical Services's weighted-average discount rate - finance leases decreased by 7.9% year-over-year, from $0.04 to $0.04.
What does weighted-average discount rate - finance leases mean?
The average interest rate used to determine the present value of finance lease liabilities.